tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Oscar Health Extends CEO Bertolini Contract and Compensation

Story Highlights
  • Oscar Health extended CEO Mark Bertolini’s contract to 2029, raising salary and bonus.
  • A $45 million RSU and PSU package with enhanced severance ties his pay to performance and control changes.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Oscar Health Extends CEO Bertolini Contract and Compensation

Claim 70% Off TipRanks Premium

Oscar Health ( (OSCR) ) has shared an announcement.

On December 22, 2025, Oscar Health, Inc. and Oscar Management Corporation amended and restated the employment agreement with Chief Executive Officer Mark T. Bertolini, extending his term from the effective date through April 1, 2029, with automatic one-year renewals thereafter unless either party opts out. The revised agreement raises Bertolini’s annual base salary to $1.3 million, increases his target annual bonus to 150% of base salary starting in 2026, and provides him with a $45 million equity package in the first quarter of 2026 split evenly between time-based RSUs and performance-based PSUs, while generally excluding him from other long-term incentive or equity awards until 2029. The contract also enhances severance protections in cases of termination without cause or for good reason, including a 1.5x cash severance and 18 months of subsidized healthcare, and sets detailed vesting and acceleration mechanics for the 2026 awards in scenarios such as qualifying terminations, death or disability, and change in control, underscoring the company’s intent to secure leadership continuity and align the CEO’s compensation with long-term performance and potential transaction outcomes.

The most recent analyst rating on (OSCR) stock is a Sell with a $12.00 price target. To see the full list of analyst forecasts on Oscar Health stock, see the OSCR Stock Forecast page.

Spark’s Take on OSCR Stock

According to Spark, TipRanks’ AI Analyst, OSCR is a Neutral.

Oscar Health’s overall stock score is primarily impacted by its financial performance challenges, including profitability and cash flow issues. While technical analysis and corporate events provide some positive signals, the negative valuation and mixed earnings call sentiment weigh heavily on the score. The company’s strategic initiatives and revenue growth offer potential, but significant hurdles remain.

To see Spark’s full report on OSCR stock, click here.

More about Oscar Health

Oscar Health, Inc. operates in the health insurance industry, offering technology-driven health plans with a focus on individual and family coverage and related managed care services through its insurance subsidiaries and management company, Oscar Management Corporation.

Average Trading Volume: 14,661,462

Technical Sentiment Signal: Sell

Current Market Cap: $3.95B

For an in-depth examination of OSCR stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1